These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19384293)

  • 1. Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy.
    Yeghiazarians Y; Zhang Y; Prasad M; Shih H; Saini SA; Takagawa J; Sievers RE; Wong ML; Kapasi NK; Mirsky R; Koskenvuo J; Minasi P; Ye J; Viswanathan MN; Angeli FS; Boyle AJ; Springer ML; Grossman W
    Mol Ther; 2009 Jul; 17(7):1250-6. PubMed ID: 19384293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-Related Impaired Efficacy of Bone Marrow Cell Therapy for Myocardial Infarction Reflects a Decrease in B Lymphocytes.
    An S; Wang X; Ruck MA; Rodriguez HJ; Kostyushev DS; Varga M; Luu E; Derakhshandeh R; Suchkov SV; Kogan SC; Hermiston ML; Springer ML
    Mol Ther; 2018 Jul; 26(7):1685-1693. PubMed ID: 29914756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with hESC-Derived Myocardial Precursors Improves Cardiac Function after a Myocardial Infarction.
    Ye J; Gaur M; Zhang Y; Sievers RE; Woods BJ; Aurigui J; Bernstein HS; Yeghiazarians Y
    PLoS One; 2015; 10(7):e0131123. PubMed ID: 26230835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.
    Yeghiazarians Y; Gaur M; Zhang Y; Sievers RE; Ritner C; Prasad M; Boyle A; Bernstein HS
    Cytotherapy; 2012 Feb; 14(2):223-31. PubMed ID: 22040108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell fusion contributes to the rescue of apoptotic cardiomyocytes by bone marrow cells.
    Yang WJ; Li SH; Weisel RD; Liu SM; Li RK
    J Cell Mol Med; 2012 Dec; 16(12):3085-95. PubMed ID: 22805279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction.
    Swijnenburg RJ; Govaert JA; van der Bogt KE; Pearl JI; Huang M; Stein W; Hoyt G; Vogel H; Contag CH; Robbins RC; Wu JC
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):77-85. PubMed ID: 19920031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes.
    Fukuhara S; Tomita S; Nakatani T; Ohtsu Y; Ishida M; Yutani C; Kitamura S
    Cell Transplant; 2004; 13(7-8):741-8. PubMed ID: 15690975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived growth factor-AB promotes the generation of adult bone marrow-derived cardiac myocytes.
    Xaymardan M; Tang L; Zagreda L; Pallante B; Zheng J; Chazen JL; Chin A; Duignan I; Nahirney P; Rafii S; Mikawa T; Edelberg JM
    Circ Res; 2004 Mar; 94(5):E39-45. PubMed ID: 14963008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous bone-marrow-derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model.
    Fukuhara S; Tomita S; Nakatani T; Yutani C; Kitamura S
    J Heart Lung Transplant; 2005 Jan; 24(1):67-72. PubMed ID: 15653382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection of human bone marrow and mononuclear cell extract into infarcted mouse hearts results in functional improvement.
    Angeli FS; Zhang Y; Sievers R; Jun K; Yim S; Boyle A; Yeghiazarians Y
    Open Cardiovasc Med J; 2012; 6():38-43. PubMed ID: 22550548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionation of mouse bone-marrow cells limits functional efficacy in non-reperfused mouse model of acute myocardial infarction.
    Koskenvuo JW; Sievers RE; Zhang Y; Angeli FS; Lee B; Shih H; Ye J; Boyle AJ; Yeghiazarians Y
    Ann Med; 2012 Dec; 44(8):829-35. PubMed ID: 22494088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. eNOS overexpressing bone marrow cells are safe and effective in a porcine model of myocardial regeneration following acute myocardial infarction.
    Ward MR; Connelly KA; Vijayaraghavan R; Vaags AK; Graham JJ; Foltz W; Hough MR; Stewart DJ; Dick A
    Cardiovasc Ther; 2013 Dec; 31(6):e72-8. PubMed ID: 23837864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcoronary delivery of bone marrow cells to the infarcted murine myocardium: feasibility, cellular kinetics, and improvement in cardiac function.
    Templin C; Kotlarz D; Marquart F; Faulhaber J; Brendecke V; Schaefer A; Tsikas D; Bonda T; Hilfiker-Kleiner D; Ohl L; Naim HY; Foerster R; Drexler H; Limbourg FP
    Basic Res Cardiol; 2006 Jul; 101(4):301-10. PubMed ID: 16705471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyocyte regeneration from circulating bone marrow cells in mice.
    Kuramochi Y; Fukazawa R; Migita M; Hayakawa J; Hayashida M; Uchikoba Y; Fukumi D; Shimada T; Ogawa S
    Pediatr Res; 2003 Sep; 54(3):319-25. PubMed ID: 12840160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of bone marrow cell therapy is more important than repeated injections after myocardial infarction.
    Zhang Y; Sievers RE; Prasad M; Mirsky R; Shih H; Wong ML; Angeli FS; Ye J; Takagawa J; Koskenvuo JW; Springer ML; Grossman W; Boyle AJ; Yeghiazarians Y
    Cardiovasc Pathol; 2011; 20(4):204-12. PubMed ID: 20667749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.
    Kajstura J; Rota M; Whang B; Cascapera S; Hosoda T; Bearzi C; Nurzynska D; Kasahara H; Zias E; Bonafé M; Nadal-Ginard B; Torella D; Nascimbene A; Quaini F; Urbanek K; Leri A; Anversa P
    Circ Res; 2005 Jan; 96(1):127-37. PubMed ID: 15569828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human bone marrow-derived mesenchymal stem cells transplanted into damaged rabbit heart to improve heart function.
    Wang JA; Fan YQ; Li CL; He H; Sun Y; Lv BJ
    J Zhejiang Univ Sci B; 2005 Apr; 6(4):242-8. PubMed ID: 15754420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective C-kit⁺ bone marrow cells attenuate apoptosis after acute myocardial infarction in mice - in-vivo assessment with fluorescence molecular imaging.
    Ale A; Siebenhaar F; Kosanke K; Aichler M; Radrich K; Heydrich S; Schiemann M; Bielicki I; Noel PB; Braren R; Maurer M; Walch AK; Rummeny EJ; Ntziachristos V; Wildgruber M
    Theranostics; 2013; 3(11):903-13. PubMed ID: 24312159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction.
    Fernández-Avilés F; San Román JA; García-Frade J; Fernández ME; Peñarrubia MJ; de la Fuente L; Gómez-Bueno M; Cantalapiedra A; Fernández J; Gutierrez O; Sánchez PL; Hernández C; Sanz R; García-Sancho J; Sánchez A
    Circ Res; 2004 Oct; 95(7):742-8. PubMed ID: 15358665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response.
    Wang X; Takagawa J; Lam VC; Haddad DJ; Tobler DL; Mok PY; Zhang Y; Clifford BT; Pinnamaneni K; Saini SA; Su R; Bartel MJ; Sievers RE; Carbone L; Kogan S; Yeghiazarians Y; Hermiston M; Springer ML
    Sci Transl Med; 2011 Sep; 3(100):100ra90. PubMed ID: 21918107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.